Relief Therapeutics
Develops innovative treatments for the affections associated with degeneration of the peripheral nervous system (neuropathy)
Relief Therapeutics has raised €16M across 2 funding rounds from 1 investor, most recently a Growth/Late round in Jul 2021. Based in Geneva, Switzerland; founded 2013; active in Healthtech. Data as of 28 Oct 2026.
Geneva, SwitzerlandFounded 2013
Total raised
€16M
€16,355,533
Funding rounds
2
Investors
1
distinct backers
Active since
2016-05
latest 2021-07
Funding by year
EUR raised per yearRelief Therapeutics — funding by year — interactive chart.
Data table
| Relief Therapeutics — funding by year | |
|---|---|
| 2016 | €2.5M |
| 2021 | €14M |
Signals
Medium confidenceRaise-next likelihood8
base rate 37% for Growth/Late
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood8
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-07-26 | Growth/Late | €14M | — | View deal → |
| 2016-05-01 | Series A | €2.5M | Global Emerging Markets | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData